Literature DB >> 27035614

Histologic Typing in Oropharyngeal Squamous Cell Carcinoma: A 4-Year Prospective Practice Study With p16 and High-Risk HPV mRNA Testing Correlation.

Dikson Dibe Gondim1, Wesley Haynes, Xiaowei Wang, Rebecca D Chernock, Samir K El-Mofty, James S Lewis.   

Abstract

Oropharyngeal squamous cell carcinomas (OPSCCs) associated with human papillomavirus (HPV) represent a distinct clinical and pathologic entity. The majority of HPV-related OPSCCs have a characteristic nonkeratinizing morphology. This study sought to determine the strength of the association between nonkeratinizing histology and HPV status compared with other squamous cell carcinoma variants in 4 years of routine clinical practice on a high-volume head and neck service. Primary and/or nodal metastatic tumors in all cases of OPSCC from 2010 to 2013 were typed by 1 of 3 head and neck pathologists as keratinizing, nonkeratinizing, nonkeratinizing with maturation, or another defined variant. All were assessed for p16 by immunohistochemistry with a 70% nuclear and cytoplasmic positivity cutoff as part of routine clinical practice. In addition, 70 consecutive cases from 1 year were "audited" for high-risk HPV mRNA by reverse transcription polymerase chain reaction and in situ hybridization. Of the 435 cases, the majority (90%) consisted of 1 of the 3 main types described and the rest (10%) of uncommon variants. Nonkeratinizing morphology had 99.1% and 100.0% positive predictive value for p16 and high-risk HPV mRNA positivity, respectively. Nonkeratinizing with maturation, keratinizing, and other specific squamous cell carcinoma variants were p16 positive in 91.8%, 22.8%, and 79.5%, respectively. All 47 nonkeratinizing OPSCCs tested for HPV mRNA were positive. In summary, strictly defined nonkeratinizing OPSCC (which constitutes ∼55% of all tumors) essentially implies positivity for both p16 and transcriptionally active high-risk HPV.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27035614     DOI: 10.1097/PAS.0000000000000650

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  16 in total

Review 1.  Data Set for the Reporting of Carcinomas of the Nasopharynx and Oropharynx: Explanations and Recommendations of the Guidelines From the International Collaboration on Cancer Reporting.

Authors:  James S Lewis; David J Adelstein; Abbas Agaimy; Diane L Carlson; William C Faquin; Tim Helliwell; Jos Hille; Tony Ng; John M Nicholls; Brian O'Sullivan; Lester D R Thompson
Journal:  Arch Pathol Lab Med       Date:  2018-11-30       Impact factor: 5.534

2.  Nonkeratinizing Squamous Cell Carcinoma In Situ of the Upper Aerodigestive Tract: An HPV-Related Entity.

Authors:  Lingxin Zhang; James S Lewis; Samir K El-Mofty; Manoj Gandhi; Rebecca D Chernock
Journal:  Head Neck Pathol       Date:  2016-08-04

Review 3.  Morphologic diversity in human papillomavirus-related oropharyngeal squamous cell carcinoma: Catch Me If You Can!

Authors:  James S Lewis
Journal:  Mod Pathol       Date:  2017-01       Impact factor: 7.842

4.  p16 immunohistochemistry in oropharyngeal squamous cell carcinoma: a comparison of antibody clones using patient outcomes and high-risk human papillomavirus RNA status.

Authors:  Jeremy Shelton; Bibianna M Purgina; Nicole A Cipriani; William D Dupont; Dale Plummer; James S Lewis
Journal:  Mod Pathol       Date:  2017-06-16       Impact factor: 7.842

Review 5.  Human papillomavirus associated head and neck squamous cell carcinoma: Controversies and new concepts.

Authors:  Nuzhat Husain; Azfar Neyaz
Journal:  J Oral Biol Craniofac Res       Date:  2017-09-01

6.  The pathology of oral cancer.

Authors:  P M Speight; P M Farthing
Journal:  Br Dent J       Date:  2018-11-09       Impact factor: 1.626

7.  Update from the 4th Edition of the World Health Organization Classification of Head and Neck Tumours: Oropharynx.

Authors:  William H Westra; James S Lewis
Journal:  Head Neck Pathol       Date:  2017-02-28

Review 8.  Clinical Utility of In Situ Hybridization Assays in Head and Neck Neoplasms.

Authors:  Peter P Luk; Christina I Selinger; Wendy A Cooper; Annabelle Mahar; Carsten E Palme; Sandra A O'Toole; Jonathan R Clark; Ruta Gupta
Journal:  Head Neck Pathol       Date:  2018-11-22

9.  Update from the 4th Edition of the World Health Organization Classification of Head and Neck Tumours: What Is New in the 2017 WHO Blue Book for Tumors and Tumor-Like Lesions of the Neck and Lymph Nodes.

Authors:  Nora Katabi; James S Lewis
Journal:  Head Neck Pathol       Date:  2017-02-28

10.  Squamous and Neuroendocrine Specific Immunohistochemical Markers in Head and Neck Squamous Cell Carcinoma: A Tissue Microarray Study.

Authors:  J S Lewis; R D Chernock; J A Bishop
Journal:  Head Neck Pathol       Date:  2017-05-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.